GREY WOLF THERAPEUTICS

grey-wolf-therapeutics-logo

Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology. Rather than targeting the immune system, Grey Wolf’s approach is to directly alter the tumour cells, illuminating them for attack and destruction by the immune system. THey are targeting the endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells, thus dramatically increasing tumour visibility and extending the reach of immunotherapy in oncology. Grey Wolf is working with leading academic and commercial drug discovery partners to deliver a clinical candidate against a strongly validated target.

#SimilarOrganizations #People #Financial #Website #More

GREY WOLF THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2017-01-01

Address:
Oxford, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.greywolftherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
+44 1865 292 038

Email Addresses:
[email protected]

Total Funding:
17.5 M GBP

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

Current Employees Featured

tom-mccarthy_image

Tom McCarthy
Tom McCarthy Co-founder & Chairman @ Grey Wolf Therapeutics
Co-founder & Chairman

peter-joyce_image

Peter Joyce
Peter Joyce Chief Executive Officer & Co-founder @ Grey Wolf Therapeutics
Chief Executive Officer & Co-founder
2018-02-01

Founder


peter-joyce_image

Peter Joyce

tom-mccarthy_image

Tom McCarthy

Investors List

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series A - Grey Wolf Therapeutics

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series A - Grey Wolf Therapeutics

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series A - Grey Wolf Therapeutics

edmond-de-rothschild-investment-partners_image

Andera Partners

Andera Partners investment in Series A - Grey Wolf Therapeutics

Official Site Inspections

http://www.greywolftherapeutics.com Semrush global rank: 4.4 M Semrush visits lastest month: 2.54 K

  • Host name: 151.101.66.159
  • IP address: 151.101.66.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Grey Wolf Therapeutics" on Search Engine